Cargando…

Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetes

BACKGROUND: The hepatokine fetuin-A, released by the human liver, promotes pro-inflammatory effects of perivascular fat. The involvement of inflammation in type 2 diabetes mellitus (T2DM) can affect the kidney and contribute to the development of diabetic kidney disease. Therefore we examined the as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magalhães, Pedro, Zürbig, Petra, Mischak, Harald, Schleicher, Erwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857838/ https://www.ncbi.nlm.nih.gov/pubmed/33564428 http://dx.doi.org/10.1093/ckj/sfaa176

Ejemplares similares

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria
por: Andersen, Sten, et al.
Publicado: (2010)

Associations of urinary polymeric immunoglobulin receptor peptides in the context of cardio-renal syndrome
por: He, Tianlin, et al.
Publicado: (2020)

Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2018)

Publisher Correction: Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2018)

Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy
por: Zürbig, Petra, et al.
Publicado: (2012)

Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray
por: Inoue, Kentaro, et al.
Publicado: (2013)

Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy
por: Krochmal, Magdalena, et al.
Publicado: (2017)

Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease
por: Pontillo, Claudia, et al.
Publicado: (2017)

Urinary proteome signature of Renal Cysts and Diabetes syndrome in children
por: Ricci, Pierbruno, et al.
Publicado: (2019)

Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?
por: Magalhães, Pedro, et al.
Publicado: (2017)

Molecular Mapping of Urinary Complement Peptides in Kidney Diseases
por: Wendt, Ralph, et al.
Publicado: (2021)

Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review
por: Catanese, Lorenzo, et al.
Publicado: (2023)

Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers
por: Jahn, Holger, et al.
Publicado: (2011)

Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2018)

Fetuin-A as a Marker of NAFLD
por: Dharmalingam, Mala, et al.
Publicado: (2021)

Left ventricular diastolic function in relation to the urinary proteome: A proof-of-concept study in a general population
por: Zhang, Zhenyu, et al.
Publicado: (2014)

Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2019)

The relationship between serum and urinary Fetuin-A levels and kidney stone formation among kidney stone patients
por: Mehrsai, Abdolrasoul, et al.
Publicado: (2017)

Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria
por: Øvrehus, Marius A, et al.
Publicado: (2015)

Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes
por: Stefan, Norbert, et al.
Publicado: (2008)

Detection and Characterization of Phosphorylation, Glycosylation, and Fatty Acid Bound to Fetuin A in Human Blood
por: Kovářová, Markéta, et al.
Publicado: (2021)

Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development
Publicado: (1975)

Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes
por: Ochieng, Josiah, et al.
Publicado: (2018)

Urinary Protein and Peptide Markers in Chronic Kidney Disease
por: Chebotareva, Natalia, et al.
Publicado: (2021)

Can Fetuin-A Be a Marker for Insulin Resistance and Poor Glycemic Control in Children with Type 1 Diabetes Mellitus?
por: Şiraz, Ülkü Gül, et al.
Publicado: (2017)

Acute kidney injury prediction in cardiac surgery patients by a urinary peptide pattern: a case-control validation study
por: Metzger, Jochen, et al.
Publicado: (2016)

The impact of Ramadan fasting on Fetuin-A level in type 2 diabetes mellitus
por: Harbuwono, Dante S., et al.
Publicado: (2021)

Identification of ageing-associated naturally occurring peptides in human urine
por: Nkuipou-Kenfack, Esther, et al.
Publicado: (2015)

Identification of Urinary Peptide Biomarkers Associated with Rheumatoid Arthritis
por: Stalmach, Angelique, et al.
Publicado: (2014)

Fetuin-A and fetal growth in gestational diabetes mellitus
por: Wang, Wen-Juan, et al.
Publicado: (2020)

Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma
por: Bannaga, Ayman, et al.
Publicado: (2021)

Serum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults
por: Song, Aiyun, et al.
Publicado: (2011)

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease
por: Lorant, David Peter, et al.
Publicado: (2011)

Association of fetuin-A with dyslipidemia and insulin resistance in type-II Diabetics of Pakistani population
por: Fatima, Fasiha, et al.
Publicado: (2020)

Urinary peptide panel for prognostic assessment of bladder cancer relapse
por: Krochmal, Magdalena, et al.
Publicado: (2019)

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker
por: Pontillo, Claudia, et al.
Publicado: (2017)

Serum fetuin‐A and Ser312 phosphorylated fetuin‐A responses and markers of insulin sensitivity after a single bout of moderate intensity exercise
por: Ren, Guang, et al.
Publicado: (2021)

Assessment of Metabolomic and Proteomic Biomarkers in Detection and Prognosis of Progression of Renal Function in Chronic Kidney Disease
por: Nkuipou-Kenfack, Esther, et al.
Publicado: (2014)

Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy
por: Roos, Marcel, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7l4ep8i7logk435f0kuvgj2hdq